Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism (Englisch)
Freier Zugriff
- Neue Suche nach: Browne, C.
- Neue Suche nach: Lanitis, T.
- Neue Suche nach: Hamilton, M.
- Neue Suche nach: Li, X.
- Neue Suche nach: Horbyluk, R.
- Neue Suche nach: Mardekian, J.
- Neue Suche nach: Kongnakorn, T.
- Neue Suche nach: Cohen, A.
- Neue Suche nach: Browne, C.
- Neue Suche nach: Lanitis, T.
- Neue Suche nach: Hamilton, M.
- Neue Suche nach: Li, X.
- Neue Suche nach: Horbyluk, R.
- Neue Suche nach: Mardekian, J.
- Neue Suche nach: Kongnakorn, T.
- Neue Suche nach: Cohen, A.
In:
Journal of Medical Economics
;
20
, 1
;
98-106
;
2017
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolism
-
Beteiligte:Browne, C. ( Autor:in ) / Lanitis, T. ( Autor:in ) / Hamilton, M. ( Autor:in ) / Li, X. ( Autor:in ) / Horbyluk, R. ( Autor:in ) / Mardekian, J. ( Autor:in ) / Kongnakorn, T. ( Autor:in ) / Cohen, A. ( Autor:in )
-
Erschienen in:Journal of Medical Economics ; 20, 1 ; 98-106
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:02.01.2017
-
Format / Umfang:9 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 20, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancerClopes, Ana / Gasol, Montse / Cajal, Rosana / Segú, Luis / Crespo, Ricard / Mora, Ramón / Simon, Susana / Cordero, Luis A / Calle, Candela / Gilabert, Antoni et al. | 2017
- 8
-
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in ScotlandParker, Christopher / Woods, Beth / Eaton, James / Ma, Esprit / Selby, Ross / Benson, Eugene / Engstrom, Andreas / Sajosi, Peter / Briggs, Andrew / Bonthapally, Vijayveer et al. | 2017
- 19
-
EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasisPickard, A. Simon / Gooderham, Melinda / Hartz, Susanne / Nicolay, Claudia et al. | 2017
- 28
-
Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched studyPunekar, Yogesh Suresh / Naya, Ian / Small, Mark / Holbrook, Tim / Wood, Robert / Mullerova, Hana / Valle, Manuel et al. | 2017
- 37
-
A comparative review of the pharmacoeconomic guidelines in South AfricaCarapinha, João L. et al. | 2017
- 45
-
Burden of illness for super-refractory status epilepticus patientsBeg, Jamil M. / Anderson, Thomas D. / Francis, Kevin / Meckley, Lisa M. / Fitzhenry, David / Foster, Todd / Sukhtankar, Susheel / Kanes, Stephen J. / Moura, Lidia M. V. R. et al. | 2017
- 54
-
The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United StatesLatremouille-Viau, Dominick / Chang, Jane / Guerin, Annie / Shi, Sherry / Wang, Ed / Yu, Justin / Ngai, Christopher et al. | 2017
- 63
-
Treatment patterns and healthcare costs among newly-diagnosed patients with chronic myeloid leukemia receiving dasatinib or nilotinib as first-line therapy in the United StatesLatremouille-Viau, Dominick / Guerin, Annie / Nitulescu, Roy / Gagnon, Patrick S. / Joseph, George J. / Chen, Lei et al. | 2017
- 72
-
Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational studyMcElroy, Heather J. / Roberts, Stuart K. / Thompson, Alex J. / Angus, Peter W. / McKenna, Sarah Jane / Warren, Emma / Musgrave, Sharon et al. | 2017
- 82
-
Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patientsAsgar, Anita W. / Khairy, Paul / Guertin, Marie-Claude / Cournoyer, Daniel / Ducharme, Anique / Bonan, Raoul / Basmadjian, Arsene / Tardif, Jean-Claude / Cohen, David J. et al. | 2017
- 91
-
Treatment patterns, complications, and direct medical costs associated with ankylosing spondylitis in Chinese urban patients: a retrospective claims dataset analysisLi, Jinghu / Liu, Qingjing / Chen, Yi / Gao, Shuangqing / Zhang, Jie / Yang, Yicheng / Chen, Wendong et al. | 2017
- 98
-
Impact of apixaban vs low molecular weight heparin/vitamin k antagonist on hospital resource use in patients with venous thromboembolismBrowne, C. / Lanitis, T. / Hamilton, M. / Li, X. / Horbyluk, R. / Mardekian, J. / Kongnakorn, T. / Cohen, A. et al. | 2017